Tag: deep vein thrombosis

COVID-19

Study finds increased risk of serious blood clots up to six...

A study from Sweden published by The BMJ recently finds an increased risk of deep vein thrombosis (DVT) up to three months after COVID-19 infection,...
Cordis

Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...

Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...

First New England enrolment into the DEXTERITY clinical trials announced

Vascular Breakthroughs and Vascular Care Connecticut have announced the first New England enrolment into the novel DEXTERITY clinical trials of local anti-inflammatory therapy to...

AVF 2022: Emerging autogenous venous valve formation system sees “continual improvement”

An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...

AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full...

Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system (Inari Medical) in a real-world deep vein...
CardioVascular Systems CSI

Cardiovascular Systems partners with Innova Vascular to develop full line of...

Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.  According to a...

Systematic review deems ablation of superficial venous reflux safe for patients...

In patients with concurrent deep venous obstruction (DVO), superficial venous reflux (SVR) ablation is suggested to be safe, according to a recent systematic review....

Abre venous stent “remains safe and effective” out to 24 months,...

The Abre venous stent (Medtronic) remains safe and effective for the treatment of iliofemoral venous obstructive disease out to 24 months. This is according...

NIH grant sets Mercator research underway for local anti-inflammatory DVT therapy

Mercator MedSystems has recently announced that the DEXTERITY trials research has begun under a technology transfer grant for approximately $300,000 funded by the National...
Roshan Bootun application of compression stockings

Compression stockings after endovenous thermal ablation of varicose veins “bring no...

A systematic review and meta-analysis published online in the European Journal of Vascular and Endovascular Surgery has suggested that, following endovenous thermal ablation of...

Recommendation for repeat imaging after incomplete ultrasound exam increases follow-up rate

The rate of follow-up after an incomplete and negative lower extremity venous duplex ultrasound (I/N LEVDUS) has been shown to increase following a specific...
Mercator Bullfrog

Mercator announces enrolment of first patient in DEXTERITY-AFP clinical trial treating...

Mercator MedSystems has announced enrolment of the first patient in the DEXTERITY (Dexamethasone therapy examining reduction of inflammation after thrombus removal to yield benefit...
VenaSeal

Five-year, single-centre VenaSeal outcomes for symptomatic saphenous incompetence revealed

Morwan Bahi (Wellington Regional Hospital, Wellington, New Zealand) presented five-year results of a retrospective, observational, single-centre study detailing outcomes for all patients with symptomatic...

Registry data show greater clot chronicity on postprocedure inspection than initially...

Nearly half of patients deemed preprocedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...

CLOUT registry: Inari Medical announces positive interim results from first 250...

Inari Medical today announced "strongly positive" interim results from the first 250 deep vein thrombosis (DVT) patients enrolled in the CLOUT (ClotTriever outcomes) registry....

Researchers recommend national registries address geographical variation in DVT guideline implementation

A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from...

New medical device removes large blood clots in DVT patients

Control Medical Technology recently announced that their US Food and Drug Administration (FDA)-cleared Control 11F mechanical thrombectomy system has been used to remove large...

Systematic review finds high risk of deep vein thrombosis and pulmonary...

In a systematic review of the worldwide published data on venous thromboembolism (VTE) in COVID-19 patients, Cihan Ay, Stephan Nopp, and Florian Moik (Medical...

Intracranial haemorrhage rare in patients treated with catheter-directed thrombolysis for proximal...

In a recent nationwide study of observational data from the USA, intracranial haemorrhage (ICH) was found to be rare among deep vein thrombosis (DVT)...

Study finds death rates from PE have been rising over the...

The American Heart Association (AHA) has announced that after nearly a decade of steady decline, the death rate for people with pulmonary embolism (PE)...

CLEAR-DVT highlights “real paradigm shift” in treatment of DVT patients

Venous News takes a look back at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) where Stephen Black (London, UK) and Mitchell Silver (Columbus, USA) discuss the CLEAR-DVT study.  Silver touches...

COVID-19 will have “massive long-term impact” on treatment of venous disease...

Manj Gohel (Cambridge, UK) is joined by a host of venous experts including Beverley Hunt (London, UK), Stephen Black (London, UK) and Ian Franklin...
Michael Lichtenberg

At six months, adjunctive mechanical thrombectomy associated with higher patency and...

A recent systematic review and meta-analysis showed that, in patients with iliofemoral deep vein thrombosis (DVT), percutaneous mechanical thrombectomy was associated with a higher...
compression

Compression stockings might not be needed to prevent blood clots after...

Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...
Jaime Benarroch-Gampel

Review of clot removal system shows positive short-term outcomes for lower...

Use of the ClotTreiver system (Inari Medical) for the treatment of lower extremity deep vein thrombosis (DVT) has demonstrated safety and efficacy, especially in...
manj-stephen

Where does the CAVA trial leave early thrombus removal for iliofemoral...

Results from the Dutch CAVA trial were published recently in The Lancet Haematology and, at first glance, this is another trial that failed to...
Susan Kahn

ATTRACT analysis finds improved quality of life for iliofemoral DVT patients...

An analysis of data from the ATTRACT trial, published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL), reveals that quality of...
pills equilis

FDA approves first generics of Eliquis for prophylaxis of DVT and...

The US Food and Drug Administration (FDA) has announced the approval of two applications for the first generics of Eliquis (apixaban) tablets, to reduce...
Suresh-ATTRACT-B-Learning

VIVA 2019: Open vein hypothesis has “validity” for DVT patients, but...

 Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las...
clottriever-VIVA-19

Clinical data on the ClotTriever system demonstrates efficacy for DVT treatment

Inari Medical has announced the presentation of early outcomes from the ClotTriever Outcomes Registry (CLOUT) using the ClotTriever Mechanical Thrombectomy System for treatment of...
Anna Pouncey

Most reinterventions following treatment of iliofemoral DVT could be due to...

Analysing the results of a retrospective, single-centre cohort study conducted at Guys and St Thomas’ Hospital, London, UK, Anna Pouncey (Guys and St Thomas’...
ATTRACT discussion

Future trials on the management of DVT “have to focus on...

Speaking at the annual meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2019; 7–11 September, Barcelona, Spain), Stephen Black (Guys and...
PTS

New ATTRACT data show catheter-based therapy significantly reduces leg symptoms and...

A new study, recently published online in the journal Circulation, reports on outcomes from a subgroup of 391 patients with acute iliofemoral deep venous...

BTG to begin European distribution of EKOS Control unit 4.0

BTG has announced that the first EKOS Control Unit 4.0 have been shipped from BTG’s facility in Bothell (Washington, USA) to Europe, where full...
Venous News for specialists

Worse outcomes in peripartum compared to non-pregnant women stented for DVT

Peripartum women with deep vein thrombosis (DVT) treated with catheter-directed thrombolysis and venous stenting had significantly increased rates of reintervention and loss of stent patency...

NexGen Medical Systems launches XCOIL large vessel thrombectomy system

NexGen Medical Systems, Inc., a US medical device company, has announced the successful completion of the first human use of their XCOIL large vessel (18mm)...

Ultrasound-enhanced catheter-directed thrombolysis as the standard of care for acute DVT

Ash Verma, Clearwater, USA, writes how last year, he happened upon a routine case that struck him as both totally unremarkable and absolutely extraordinary....